Loading…
Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development
Activating mutations in the KRAS oncogene are associated with three related human syndromes, which vary in hair and skin phenotypes depending on the involved allele. How variations in RAS signals are interpreted during hair and skin development is unknown. In this study, we investigated the developm...
Saved in:
Published in: | Developmental biology 2013-01, Vol.373 (2), p.373-382 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Activating mutations in the KRAS oncogene are associated with three related human syndromes, which vary in hair and skin phenotypes depending on the involved allele. How variations in RAS signals are interpreted during hair and skin development is unknown. In this study, we investigated the developmental and transcriptional response of skin and hair to changes in RAS activity, using mouse genetic models and microarray analysis. While activation of Kras (KrasG12D) in the skin had strong effects on hair growth and hair shape, steady state changes in downstream RAS/MAPK effectors were subtle and detected only by transcriptional responses. To model the transcriptional response of multiple developmental pathways to active RAS, the effects of growth factor stimulation were studied in skin explants. Here FGF acutely suppressed Shh transcription within 90min but had significantly less effect on Eda, WNT, Notch or BMP pathways. Furthermore, in vivo Fgfr2 loss-of-function in the ectoderm caused derepression of Shh, revealing a role for FGF in Shh regulation in the hair follicle. These studies define both dosage sensitive effects of RAS signaling on hair morphogenesis and reveal acute mechanisms for fine-tuning Shh levels in the hair follicle.
► Hair shaft defects result from ectodermal activation of Kras in mice. ► Shh is a RAS-responsive target gene. ► Shh levels acutely respond to FGF stimulation or MAPK/PI3K inhibition. ► Shh RNA has a short half-life and its levels are dependent on transcription. ► Ectodermal Fgfr2 regulates Shh levels in vivo. |
---|---|
ISSN: | 0012-1606 1095-564X |
DOI: | 10.1016/j.ydbio.2012.10.024 |